Research graph
References from Menopause following cancer treatment-induced menopause: unique considerations and current recommendations. Local targets link to admitted publications; unresolved targets remain external evidence.
The role of lifestyle medicine in menopausal health: a review of non-pharmacologic interventions
10.1080/13697137.2025.2548806 · 2025 · External reference
Effectiveness of group and self-help cognitive behavior therapy in reducing problematic menopausal hot flushes and night sweats (MENOS 2): a randomized controlled trial
10.1097/gme.0b013e31823fe835 · 2012 · External reference
Efficacy of pharmacological therapies for the prevention of fractures in postmenopausal women: a network meta-analysis
10.1210/jc.2019-00192 · 2019 · External reference
Evaluating the efficacy of vaginal for vaginal symptoms in postmenopausal cancer survivors: NCCTG N10C1 (alliance)
2018 · External reference
Sexual dysfunction in women on adjuvant endocrine therapy after breast cancer
10.1097/gme.0b013e31826560da · 2013 · External reference
Integrating menopause care into oncology: implementation of a multidisciplinary oncology–menopause meeting for gynaecological cancer survivors
10.1016/j.ijgc.2025.103161 · 2026 · External reference
Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer
10.1007/s10549-015-3511-3 · 2015 · External reference
Gonadotropin-releasing hormone and its analogues
10.1056/nejm199101103240205 · 1991 · External reference
Gut-brain communication in menopause: insights into neuroendocrine and microbiome interactions
10.1017/s0029665126102201 · 2026 · External reference
The effect of transdermal testosterone on mammographic density in postmenopausal women not receiving systemic estrogen therapy
10.1210/jc.2009-1523 · 2009 · External reference
Ospemifene for the treatment of vulvar and vaginal atrophy: a meta-analysis of randomized trials. Part I: evaluation of efficacy
10.1016/j.maturitas.2018.11.016 · 2019 · External reference
Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials
10.1016/s0140-6736(15)60908-4 · 2015 · External reference
Effects of letrozole on serum estradiol and estrone in postmenopausal breast cancer patients and tolerability of treatment: a prospective trial using a highly sensitive LC–MS/MS (liquid chromatography–tandem mass spectrometry) method for estrogen measurement
10.1007/s10549-023-07054-3 · 2023 · External reference
Cardiovascular disease risk among cancer survivors
10.1016/j.jacc.2022.04.042 · 2022 · External reference
Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study
10.1007/s10549-007-9523-x · 2007 · External reference
Systematic review of acceptability, cardiovascular, neurological, bone health and HRT outcomes following risk reducing surgery in BRCA carriers
10.1016/j.bpobgyn.2020.01.006 · 2020 · External reference
Association of age at menopause and duration of reproductive period with depression after menopause: a systematic review and meta-analysis
10.1001/jamapsychiatry.2015.2653 · 2016 · External reference
Menopausal symptoms in epithelial ovarian cancer survivors: a GINECO VIVROVAIRE2 study
10.1016/j.ygyno.2021.10.001 · 2021 · External reference
Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment
10.1093/annonc/mdl030 · 2006 · External reference
The global prevalence of primary ovarian insufficiency and early menopause: a meta-analysis
10.1080/13697137.2019.1574738 · 2019 · External reference
Breast Cancer, Version 4.2026, NCCN Clinical Practice Guidelines In Oncology
10.6004/jnccn.2026.0033 · 2026 · External reference
Managing menopause after cancer
10.1016/s0140-6736(23)02802-7 · 2024 · External reference
What happens after menopause? (WHAM): a prospective controlled study of vasomotor symptoms and menopause-related quality of life 12 months after premenopausal risk-reducing salpingo-oophorectomy
10.1016/j.ygyno.2021.07.029 · 2021 · External reference
PERCEIVE: a retrospective, qualitative interview-based study of the impact of vasomotor symptoms associated with menopause on the lives of individuals who are not suitable candidates for hormone therapy
10.1016/j.maturitas.2025.108670 · 2025 · External reference
Does a multidisciplinary menopausal symptoms after cancer clinic reduce symptoms?
2022 · External reference
Unresolved reference
External reference
Biology and receptor interactions of estriol and estriol derivatives in vitro and in vivo
1984 · External reference
Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial
10.1016/s1470-2045(08)70341-3 · 2009 · External reference
Applying a life course biological age framework to improving the care of individuals with adult cancers: review and research recommendations
10.1001/jamaoncol.2021.1160 · 2021 · External reference
Nature and severity of menopausal symptoms and their impact on quality of life and sexual function in cancer survivors compared with women without a cancer history
10.1097/gme.0b013e3182976f46 · 2014 · External reference
The menopause specialist and breast cancer survivorship
10.1177/2053369116668738 · 2016 · External reference
Toxicity of chemotherapy and radiation on female reproduction
10.1097/grf.0b013e3181f96b54 · 2010 · External reference
Menopause care: alternatives to hormone replacement therapy
10.1111/tog.70010 · 2025 · External reference
Aromatase inhibitors as adjuvant therapy in early breast cancer: insights into toxicities and their management
10.3390/cancers17172726 · 2025 · External reference
Top ten menopause research priorities
10.1016/s0140-6736(24)02602-3 · 2024 · External reference
Menopause: management – management of menopause, perimenopause, or premature ovarian insufficiency
External reference
DailyMed: SOLTAMOX – tamoxifen citrate liquid
External reference
Evidence-based guideline: premature ovarian insufficiency
10.1093/hropen/hoae065 · 2024 · External reference
Experiencing menopause in the context of cancer: women’s constructions of gendered subjectivities
10.1080/08870446.2017.1320799 · 2017 · External reference
Who is managing menopausal symptoms, sexual problems, mood and sleep disturbance after breast cancer and is it working? Findings from a large community-based survey of breast cancer survivors
10.1007/s10549-021-06117-7 · 2021 · External reference
Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement
10.1210/jc.2013-4145 · 2014 · External reference
Hormone replacement therapy and the risk of venous thromboembolism: a population-based study
10.1111/j.1538-7836.2010.03839.x · 2010 · External reference
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause
10.1212/01.wnl.0000276984.19542.e6 · 2007 · External reference
Chemobrain and cancer survivorship: a scoping review of the literature
10.1002/cam4.71383 · 2025 · External reference
The role of cyclin-dependent kinases (CDK) 4/6 in the ovarian tissue and the possible effects of their exogenous inhibition
10.3390/cancers15204923 · 2023 · External reference
The silent grief: psychosocial aspects of premature ovarian failure
10.3109/13697137.2011.571320 · 2011 · External reference
Effects of self-reported age at nonsurgical menopause on time to first fracture and bone mineral density in the Women’s Health Initiative Observational Study
10.1097/gme.0000000000000451 · 2015 · External reference
Unresolved reference
2025 · External reference
Effect of primary ovarian insufficiency and early natural menopause on mortality: a meta-analysis
10.3109/13697137.2015.1094784 · 2016 · External reference
Safety and efficacy of topical testosterone in breast cancer patients receiving ovarian suppression and aromatase inhibitor therapy
10.1186/s13058-024-01886-7 · 2024 · External reference
10.1177/20533691241286666
10.1177/20533691241286666 · 2024 · External reference
Endogenous hormones and risk of invasive breast cancer in pre- and post-menopausal women: findings from the UK Biobank
10.1038/s41416-021-01392-z · 2021 · External reference
Association of muscle disorders in late postmenopausal women according to the type of experienced menopause
10.1097/gme.0000000000002367 · 2024 · External reference
Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases
10.1136/bmj.k4810 · 2019 · External reference
Complications of pelvic radiation in patients treated for gynecologic malignancies
10.1002/cncr.28849 · 2014 · External reference
Fertility preservation for young patients with cancer: who is at risk and what can be offered?
10.1016/s1470-2045(05)70092-9 · 2005 · External reference
Changes of hormone levels for postmenopausal women after bilateral oophorectomy: a meta-analysis
2025 · External reference
Fracture risk prediction using the fracture risk assessment tool in individuals with cancer
10.1001/jamaoncol.2024.4318 · 2024 · External reference
Positive impact of a co-designed digital resource for women with early menopause
10.1097/gme.0000000000001972 · 2022 · External reference
#490 National Cancer Research Institute (NCRI) survey of hormone replacement therapy prescribing in gynaecological and breast cancer survivors and in women who have had risk-reducing oophorectomy in the United Kingdom
2023 · External reference
Risk of cancer with hormone replacement therapy: a narrative review
2026 · External reference
Vitamin D concentration among women with gynecological cancers
10.3390/cancers17121987 · 2025 · External reference
Association between premature ovarian insufficiency and biological aging
10.1093/ejendo/lvaf102 · 2025 · External reference
Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data
10.1016/s2468-2667(19)30155-0 · 2019 · External reference
Type of menopause, age of menopause and variations in the risk of incident cardiovascular disease: pooled analysis of individual data from 10 international studies
10.1093/humrep/deaa124 · 2020 · External reference
